Prabhjot S. Mundi

Prabhjot S. Mundi

Hematology
161 Fort Washington Avenue
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Male Breast Cancer: From Extrapolated Practice to Evidence-Based Care.

Male Breast Cancer: From Extrapolated Practice to Evidence-Based Care.

Journal: The oncologist
Published: June 03, 2026

Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor.

Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.

Journal: JAMA network open
Published: November 04, 2025

Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy.

Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy.

Journal: bioRxiv : the preprint server for biology
Published: May 27, 2024

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Journal: bioRxiv : the preprint server for biology
Published: May 20, 2024

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Journal: The Journal of clinical investigation
Published: May 01, 2024

Elucidating Compound Mechanism of Action and Polypharmacology with a Large-scale Perturbational Profile Compendium.

Elucidating Compound Mechanism of Action and Polypharmacology with a Large-scale Perturbational Profile Compendium.

Journal: bioRxiv : the preprint server for biology
Published: October 24, 2023

A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.

A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.

Journal: The oncologist
Published: August 10, 2023

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 19, 2023

A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.

A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.

Journal: Cancer discovery
Published: September 12, 2022

Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.

Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.

Journal: Seminars in oncology
Published: July 18, 2022

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.

Journal: Frontiers in oncology
Published: June 22, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026